Phosphorylation of ezrin by cyclin-dependent kinase 5 induces the release of rho GDP dissociation inhibitor to inhibit Rac1 activity in senescent cells.
被引:28
|
作者:
Yang, HS
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USATufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
Yang, HS
[1
]
Hinds, PW
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USATufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
Hinds, PW
[1
]
机构:
[1] Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
Normal somatic cells enter a state of irreversible proliferation arrest-designated cellular senescence, which is characterized by biochemical changes and a distinctive morphology. Cellular stresses, including oncogene activation, can lead to senescence. Consistent with an antioncogenic role in this process, the tumor suppressor pRb plays a critical role in senescence. Reexpression of pRb in human tumor cells results in senescence-like changes, including cell cycle exit and cell shape alteration. Here, we show that pRb-induced senescent SAOS-2 cells and senescent human diploid fibroblasts are accompanied by increased phosphorylation of ezrin at T235 by cyclin-dependent kinase 5 and consequent dissociation of Rho GDP dissociation inhibitor (Rho-GDI) from an ezrin/RhoGDI complex. The release of Rho-GDI results in increased interaction with Rac1 GTPase and inhibition of Rac1 GTPase activity. In addition, reduction of Rho-GDI by small interfering RNA in pRb-transfected cells prevented senescence-associated flat cell formation, suggesting that Rho-GDI plays an important role in contributing to cellular morphology in the process of senescence.